mer sold 1200 December 75 calls at $1.70 and $1.75, possibly to overwrite an equity position. IDIX ($5.15 +0.2%) following the Roche acquisition of Anadys, a bullish customer sold the November 5 puts and bought the Jan 7.5 calls 8000x paying up to $0.30 for the package. Secondaries (announced/priced):